Washington, Feb 2 (IANS) US drugmaker Pfizer has applied to the Food and Drug Administration (FDA) to authorise two doses of their Covid vaccine for children younger than five years, the media reported. Although a clinical trial among children in the
New York, Nov 20 (IANS) The United States Centers for Disease Control and Prevention (CDC) endorsed booster doses of Pfizer/BioNTech’s and Moderna’s Covid-19 vaccines for all US adults. “CDC continues to encourage the 47 million adults who are not yet vaccinated
Washington, Sep 27 (IANS) Pfizer is soon expected to submit data to the US Food and Drug Administration (FDA) regarding safety of its mRNA Covid vaccine for children ages 5 to 11, media reports said. “It’s a question of days, not
London, Sep 10 The UK’s health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country’s decision on the third dose remains pending. “We know that a person’s immunity may decline over time after
New York, May 24 Pfizer on Monday announced a study to explore coadministration of its pneumococcal vaccine along with a third dose of the Pfizer-BioNTech Covid-19 vaccine in older adults. Pfizer, in a statement, announced that “the first enrolled subjects
New York, May 5 Pfizer is discussing expedited approval of its Covid-19 vaccine with the Indian government, company CEO Alber Bourla said while announcing a donation of medicines worth $70 million to fight the resurgent pandemic. “We are currently discussing
London, April 28 A single dose of a Pfizer or AstraZeneca vaccine against coronavirus disease can reduce transmission by up to 50 per cent, finds a study. The study led by UK’s Public Health England (PHE) showed that people who
New Delhi, April 22 US pharma major Pfizer on Thursday offered to supply the Pfizer-BioNTech vaccine at a “not-for-profit” price, media reports have cited. The company had earlier said that it will supply the messenger RNA (mRNA) vaccine only through government
Moscow, Nov 23 Russia’s Sputnik V vaccine against Covid-19 will cost governments much lower than that of Pfizer’s and Moderna’s, the official Twitter handle of the world’s first registered vaccine against the pandemic said on Sunday. “Translating pharma lingo: the
New York, Nov 20 Pfizer announced Friday it is seeking emergency approval from US regulators for its Covid-19 vaccine, which has shown 95 percent efficacy in a totality of two data sets released in the last 10 days. The chief
New York, Nov 20 Pfizer on Friday announced that it is moving ahead with its request of asking the US regulators to allow emergency use of its Covid-19 vaccine, which has shown 95 per cent efficacy in a totality of
New York, Nov 18 Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their two-dose coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age
New York, Aug 26 University Hospitals (UH) in the US has been selected as the clinical site to test for the Phase 2/3 of a possible Covid-19 vaccine — BNT162b2 — sponsored by the US-based pharmaceutical major Pfizer and German
New York, July 23 The US government has agreed to pay $1.95 billion for 100 million doses of a potential Covid-19 vaccine jointly developed by Pfizer and BioNTech, the two companies said on Wednesday. The doses of the vaccine, BNT162,
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
 |
